Adjuvant effect of multi-CpG motifs on an HIV-1 DNA vaccine

被引:100
作者
Kojima, Y
Xin, KQ
Ooki, T
Hamajima, K
Oikawa, T
Shinoda, K
Ozaki, T
Hoshino, Y
Jounai, N
Nakazawa, M
Klinman, D
Okuda, K [1 ]
机构
[1] Yokohama City Univ, Sch Med, Dept Bacteriol, Yokohama, Kanagawa 2360004, Japan
[2] Yokohama City Univ, Sch Med, Dept Parasitol, Yokohama, Kanagawa 2360004, Japan
[3] US FDA, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA
关键词
CpG motif; DNA vaccine; HIV; dendritic cells;
D O I
10.1016/S0264-410X(02)00238-4
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Synthetic oligodeoxynucleotides (ODN) containing unmethylated CpG motifs trigger an immune response characterized by the activation of B cells, NK cells and monocytes/macrophages. Based on evidence that the immunogenicity of DNA vaccines can be augmented by the addition of CpG motifs, 5-20 additional CpG motifs were cloned into a pUC-derived plasmid. Treating bone-marrow derived dendritic cells (BM-DCs) with CpG-enriched plasmids in vitro boosted their expressions of MHC class II molecules, the CD40 and CD86 activation markers. Co-administering the CpG-enriched plasmids with a DNA vaccine encoding the envelope glycoprotein of HIV to BALB/c mice significantly increased HIV-specific cell mediated and humoral immunity. A significant boost was observed when the CpG plasmid was administered either 2 or 4 days after DNA vaccination. Plasmids containing 20 CpG copies were the most effective immune enhancers both in vitro and in vivo. These results suggest that plasmids containing multiple CpG motifs may improve the immunogenicity of DNA vaccines. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:2857 / 2865
页数:9
相关论文
共 39 条
[1]   Phenotypic analysis of antigen-specific T lymphocytes [J].
Altman, JD ;
Moss, PAH ;
Goulder, PJR ;
Barouch, DH ;
McHeyzerWilliams, MG ;
Bell, JI ;
McMichael, AJ ;
Davis, MM .
SCIENCE, 1996, 274 (5284) :94-96
[2]   8 Br-cAMP enhances both humoral and cell-mediated immune responses induced by an HIV-1 DNA vaccine [J].
Arai, H ;
Xin, KQ ;
Hamajima, K ;
Lu, Y ;
Watabe, S ;
Takahashi, T ;
Toda, S ;
Okuda, K ;
Kudoh, I ;
Suzuki, M ;
Okuda, K .
GENE THERAPY, 2000, 7 (08) :694-702
[3]  
Ballas ZK, 1996, J IMMUNOL, V157, P1840
[4]   The effects of DNA containing CpG motif on dendritic cells [J].
Behboudi, S ;
Chao, D ;
Klenerman, P ;
Austyn, J .
IMMUNOLOGY, 2000, 99 (03) :361-366
[5]   Help for cytotoxic-T-cell responses is mediated by CD40 signalling [J].
Bennett, SRM ;
Carbone, FR ;
Karamalis, F ;
Flavell, RA ;
Miller, JFAP ;
Heath, WR .
NATURE, 1998, 393 (6684) :478-480
[6]   ANTIBODY-RESPONSES RAISED AGAINST A CONFORMATIONAL V3 LOOP PEPTIDE OF HIV-1 [J].
BUKAWA, H ;
FUKUSHIMA, J ;
HAMAJIMA, K ;
KIMURA, M ;
TSUJI, T ;
XIN, KQ ;
OKUDA, K .
MICROBIOLOGY AND IMMUNOLOGY, 1995, 39 (08) :607-614
[7]  
CLERICI M, 1991, J IMMUNOL, V146, P2214
[8]   CpG DNA overcomes hyporesponsiveness to hepatitis B vaccine in orangutans [J].
Davis, HL ;
Suparto, I ;
Weeratna, R ;
Jumintarto ;
Iskandriati, D ;
Chamzah, S ;
Ma'ruf, A ;
Nente, C ;
Pawitri, D ;
Krieg, AM ;
Heriyanto ;
Smits, W ;
Sajuthi, D .
VACCINE, 2000, 18 (18) :1920-1924
[9]  
Elkins KL, 1999, J IMMUNOL, V162, P2291
[10]   Mechanism and function of a newly identified CpG DNA moth in human primary B cells [J].
Hartmann, G ;
Krieg, AM .
JOURNAL OF IMMUNOLOGY, 2000, 164 (02) :944-952